Inventor · disambiguated record
Evren Alici
Also filed as: ALICI EVREN
3 granted patents·9 pending applications·23 citations·filing 2007–2024
64Inventor score
Files withCELLPROTECT NORDIC PHARMACEUTICALS AB3VYCELLIX INC3ALICI EVREN2AVARIS AB1MORPHOGENESIS INC1
Top patents by PatentIndex Score
12 records- 0180US8877182B2Expansion of NK cellsALICI EVREN·Filed 2010·Granted Nov 4, 2014·21 cites·27 claims
- 0273US9585914B2Expanded NK cellsCELLPROTECT NORDIC PHARMACEUTICALS AB·Filed 2015·Granted Mar 7, 2017·2 cites·6 claims
- 0365US2025332187A1Novel rna construct and methods of use thereof for enhancing the therapeutic effects of cytotoxic cells and stem cellsVYCELLIX INC·Filed 2024·Application pending·0 cites
- 0464US2023183690A1Exosome delivery of cancer therapeuticsMORPHOGENESIS INC·Filed 2022·Application pending·0 cites
- 0562US2009123442A1Expanded nk cellsAVARIS AB·Filed 2007·Application pending·0 cites
- 0657US2025205282A1Genetically engineered antibody resistant (gear) cells for adoptive cellular therapyVYGEN BIO INC·Filed 2023·Application pending·0 cites
- 0756US12128061B2RNA construct and methods of use thereof for enhancing the therapeutic effects of cytotoxic cells and stem cellsVYCELLIX INC·Filed 2018·Granted Oct 29, 2024·0 cites·17 claims
- 0854US2020239845A1Expanded nk cellsCELLPROTECT NORDIC PHARMACEUTICALS AB·Filed 2020·Application pending·0 cites
- 0952US2025034226A1Chimeric switch receptors in nk cellsALICI EVREN·Filed 2022·Application pending·0 cites
- 1051US2017145383A1Expanded nk cellsCELLPROTECT NORDIC PHARMACEUTICALS AB·Filed 2017·Application pending·0 cites
- 1142US2021186977A1Medical usesXNK Therapeutics AB·Filed 2019·Application pending·0 cites
- 1241US2023272035A1Modulators of the immune escape mechanism for universal cell therapyVYCELLIX INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Evren Alici files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →